Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
about
Very Late Stent Thrombosis 11 Years after Implantation of a Drug-Eluting StentImpact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantationFusion of 3D QCA and IVUS/OCT.In vivo comparison of arterial lumen dimensions assessed by co-registered three-dimensional (3D) quantitative coronary angiography, intravascular ultrasound and optical coherence tomography.Angioplasty of unprotected left main coronary stenosis: Real world experience of a single-operator group from eastern India.Impact of stent mis-sizing and mis-positioning on coronary fluid wall shear and intramural stress.Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyLate thrombosis of sirolimus-eluting stent: a multifactorial problem.Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities.Robotic-assisted angioplasty: current status and future possibilities.QCA, IVUS and OCT in interventional cardiology in 2011.Comparison of two dimensional quantitative coronary angiography (2D-QCA) with optical coherence tomography (OCT) in the assessment of coronary artery lesion dimensions.Robotic technology in interventional cardiology: Current status and future perspectives.Current and Future Use of Robotic Devices to Perform Percutaneous Coronary Interventions: A ReviewIntravascular ultrasound-guided drug-eluting stent implantation.Computational fluid dynamics applied to virtually deployed drug-eluting coronary bioresorbable scaffolds: Clinical translations derived from a proof-of-conceptRelationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery.Longitudinal Geographic Miss (LGM) in Robotic Assisted Versus Manual Percutaneous Coronary Interventions.OCT-measured plaque free wall angle is indicative for plaque burden: overcoming the main limitation of OCT?Geographical miss is associated with vulnerable plaque and increased major adverse cardiovascular events in patients with myocardial infarction.The Development of Robotic Technology in Cardiac and Vascular InterventionsDiagnosis and management challenges of in-stent restenosis in coronary arteries.Predictors and incidence of stent edge dissections in patients with type 2 diabetes as determined by optical coherence tomography.Impact of the clinical syntax score on 5-year clinical outcomes after sirolimus-eluting stents implantation.Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET).Interoperator and intraoperator (in)accuracy of stent selection based on visual estimation.Robotics in percutaneous cardiovascular interventions.Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study.Robotic-assisted percutaneous coronary intervention.Robotic-Assisted Percutaneous Coronary Intervention: Rationale, Implementation, Case Selection and Limitations of Current Technology.Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.Robotically assisted percutaneous coronary intervention: benefits to the patient and the cardiologist.Complex robotic-enhanced percutaneous coronary intervention.Novel Method for Real Time Co-Registration of IVUS and Coronary Angiography.A novel system for the reconstruction of a coronary artery lumen profile in real time: a preclinical validation.New insights on acute expansion and longitudinal elongation of bioresorbable vascular scaffolds in vivo and at bench test: a note of caution on reliance to compliance charts and nominal length.Impact of coronary artery stent edge dissections on long-term clinical outcome in patients with acute coronary syndrome: an optical coherence tomography study.Impact of type 2 diabetes mellitus and glucose control on fractional flow reserve measurements in intermediate grade coronary lesions.Classification of calcium in intravascular OCT images for the purpose of intervention planning.
P2860
Q26778663-17782756-51BB-4342-BD17-1FF0D232E2D7Q28544097-8449938B-DDDB-404F-80E2-045F3C02BBE7Q34804267-04303D9A-A820-43B2-B40D-BEB8D6629A11Q36296060-FE8B89DA-33C9-4A93-A9BA-83297FB0F35DQ36595333-530A179F-AD06-452F-8D4B-9C494B1A609DQ37054647-B47FBE1D-5FD5-47D7-B832-B25897FD7883Q37396871-D061C916-A2AA-4110-B962-04BF162249DDQ37412158-3413098F-0E8E-4E6B-9FAE-979B51D7BCAEQ37833551-FDFBEE81-8E8C-4B19-A18C-5758F9259A1CQ38029560-4FA2A1BE-AFD5-430E-AF3E-7DE7BF24BB6BQ38166727-410DB71E-6D40-4C48-A29E-74732CEC9C41Q38635731-69999EE8-4E0E-44C2-B403-A221015DE30FQ38644562-67F49702-B669-4398-B831-DB2B3BD858A9Q38652447-3AE5C766-2AC4-4DD1-AA1E-9558EC0634A4Q39002367-C1775E3A-D72F-47A9-87E2-7AD29E8FCF3FQ39287110-60AC0572-BDF7-4B5F-A925-1C35EAF328CFQ39743831-84F1F851-74FD-4DA0-8911-53CE905C3B10Q40405516-63344E05-E088-42A9-B792-E75B74A77949Q41081925-8F2EFFCA-2FD7-4997-AEE0-F37C25BFCEFFQ41156296-41677377-26AE-4A46-8698-09C9D3558A04Q41299504-B64255B9-C41C-4B65-8D04-DA3B903E954CQ41608247-EBF0B3B0-838E-4769-9698-5F9FE6F5EA4EQ43858257-4ED101E8-2C40-408B-98AF-0471012C87B9Q43995107-D5AA108C-C40E-430F-9D1B-BD648424A7D7Q44927112-28BD8CF8-4D94-48F7-AE26-D24AB9ACCF09Q46093927-58D4C105-B128-407A-A863-451A26BF1985Q46214587-038A7534-3DA0-49BB-808F-18C69A8EC965Q46510109-54A6FD40-C149-4D48-910A-E79874748669Q47643084-2F424076-94F2-46D7-8A05-0448F86698AFQ48103286-0C8188DD-0C1E-497E-B84C-4E43B0646C9FQ48132230-5ED614E7-4E66-405B-A1F1-087DB758B6F7Q48290973-6F155C9D-576B-431A-86A7-A7CC3965434AQ48383812-EF8B27AB-AD3A-4611-9DD9-5C457586138DQ51147393-7EE8BBA9-5C33-48CC-81D9-AF364F5E5756Q51542929-B10B49DA-565E-48E8-A8A5-4838908747A7Q51827820-B0862953-11B2-499D-BD8A-27F8764828EAQ53465705-F2A2C006-0AB6-4747-BECD-1C1390EC0B84Q53628726-D7A56469-94D4-457E-A1FD-E3A715C98C4FQ54043286-45606EE1-A34F-4759-B11A-33B56F7D5B5EQ55005252-B86874A4-1A20-44B5-B9D6-449E335FD8AB
P2860
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Impact of stent deployment pro ...... nter prospective STLLR trial).
@en
Impact of stent deployment pro ...... ty of sirolimus-eluting stents
@nl
type
label
Impact of stent deployment pro ...... nter prospective STLLR trial).
@en
Impact of stent deployment pro ...... ty of sirolimus-eluting stents
@nl
prefLabel
Impact of stent deployment pro ...... nter prospective STLLR trial).
@en
Impact of stent deployment pro ...... ty of sirolimus-eluting stents
@nl
P2093
P1476
Impact of stent deployment pro ...... nter prospective STLLR trial).
@en
P2093
Alan Niederman
Bruce Flieshman
Dominick J Angiolillo
Fayez Shamoon
John Patterson
Joseph Battaglia
Marco A Costa
Mark Tannenbaum
Mitchell Driesman
P304
P356
10.1016/J.AMJCARD.2008.02.053
P407
P577
2008-04-09T00:00:00Z